Page last updated: 2024-08-18

trehalose and Idiopathic Parkinson Disease

trehalose has been researched along with Idiopathic Parkinson Disease in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (6.67)29.6817
2010's8 (53.33)24.3611
2020's6 (40.00)2.80

Authors

AuthorsStudies
Akopyan, AA; Dubrovina, NI; Ovsyukova, MV; Pupyshev, AB; Tenditnik, MV; Tikhonova, MA1
Choi, HJ; Huh, YE; Kwon, Y; Moon, SH1
Correia, MAS; Gallardo, E; Gonçalves, AM; Oliveira, AE; Oliveira, DM; Passarinha, LA; Pedro, AQ; Queiroz, JA; Romão, MJ; Santos, MFA1
Garcia-Garcia, A; Gopar-Cuevas, Y; Loera-Arias, MJ; Montes-de-Oca-Luna, R; Rodriguez-Rocha, H; Saucedo-Cardenas, O1
Dubey, SK; K C, S; Kakoty, V; Kesharwani, P; Taliyan, R; Yang, CH1
Dubey, SK; K C, S; Kakoty, V; Taliyan, R; Yang, CH1
Cho, ED; Jung Ahn, W; Lee, HJ; Lee, SJ; Won Lee, K; Yoon, YS1
Agarwal, M; Deep, S; Katyal, N; Kumar, V; Sen, R1
Akopyan, AA; Dubrovina, NI; Korolenko, TA; Pupyshev, AB; Tenditnik, MV; Tikhonova, MA1
Hoffmann, AC; Kazman, A; Klucken, J; Menges, S; Mielenz, D; Minakaki, G; Salvi, R; Savitskiy, S; Vicente Miranda, H; Winkler, J; Xiang, W1
Barreto, GE; Khalifeh, M; Sahebkar, A1
Bellomo, G; Parnetti, L1
Brotchie, JM; He, Q; Koprich, JB; Wang, J; Wang, Y; Xiao, BG; Yu, WB1
Darley-Usmar, V; Redmann, M; Volpicelli-Daley, L; Wani, WY; Zhang, J1
Davies, JE; Huang, Z; Rubinsztein, DC; Sarkar, S; Tunnacliffe, A1

Reviews

2 review(s) available for trehalose and Idiopathic Parkinson Disease

ArticleYear
The gut-brain connection in the pathogenicity of Parkinson disease: Putative role of autophagy.
    Neuroscience letters, 2021, 05-14, Volume: 753

    Topics: alpha-Synuclein; Animals; Autophagy; Brain; Disease Models, Animal; Dysbiosis; Gastrointestinal Microbiome; Humans; Intestinal Mucosa; Parkinson Disease; Protein Aggregates; Trehalose

2021
Trehalose as a promising therapeutic candidate for the treatment of Parkinson's disease.
    British journal of pharmacology, 2019, Volume: 176, Issue:9

    Topics: Animals; Humans; Neuroprotective Agents; Parkinson Disease; Trehalose

2019

Other Studies

13 other study(ies) available for trehalose and Idiopathic Parkinson Disease

ArticleYear
Restoration of Parkinson's Disease-Like Deficits by Activating Autophagy through mTOR-Dependent and mTOR-Independent Mechanisms in Pharmacological and Transgenic Models of Parkinson's Disease in Mice.
    Bulletin of experimental biology and medicine, 2021, Volume: 171, Issue:4

    Topics: Adenine; Animals; Autophagy; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mice, Transgenic; MTOR Inhibitors; Neuroinflammatory Diseases; Neuroprotective Agents; Parkinson Disease; Parkinson Disease, Secondary; Signal Transduction; Sirolimus; Substantia Nigra; TOR Serine-Threonine Kinases; Trehalose

2021
Trehalose ameliorates prodromal non-motor deficits and aberrant protein accumulation in a rotenone-induced mouse model of Parkinson's disease.
    Archives of pharmacal research, 2022, Volume: 45, Issue:6

    Topics: Animals; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Olfaction Disorders; Parkinson Disease; Prodromal Symptoms; Rotenone; Trehalose; Tyrosine 3-Monooxygenase

2022
Thermofluor-Based Optimization Strategy for the Stabilization of Recombinant Human Soluble Catechol-
    International journal of molecular sciences, 2022, Oct-14, Volume: 23, Issue:20

    Topics: Carboxy-Lyases; Catechol O-Methyltransferase; Catechols; Cysteine; Dopamine; Estrogens; Glycerol; Humans; Ionic Liquids; Levodopa; Metanephrine; Parkinson Disease; Trehalose

2022
Metformin and Trehalose-Modulated Autophagy Exerts a Neurotherapeutic Effect on Parkinson's Disease.
    Molecular neurobiology, 2023, Volume: 60, Issue:12

    Topics: Aged; Animals; Autophagy; Dopamine; Humans; Metformin; Mice; Mice, Inbred C57BL; Neuroblastoma; Parkinson Disease; Trehalose

2023
Neuroprotective Effects of Trehalose and Sodium Butyrate on Preformed Fibrillar Form of α-Synuclein-Induced Rat Model of Parkinson's Disease.
    ACS chemical neuroscience, 2021, 07-21, Volume: 12, Issue:14

    Topics: alpha-Synuclein; Animals; Butyric Acid; Disease Models, Animal; Neuroprotective Agents; Parkinson Disease; Rats; Rats, Wistar; Trehalose

2021
Is trehalose an autophagic inducer? Unraveling the roles of non-reducing disaccharides on autophagic flux and alpha-synuclein aggregation.
    Cell death & disease, 2017, 10-05, Volume: 8, Issue:10

    Topics: alpha-Synuclein; Animals; Autophagosomes; Autophagy; Cell Survival; Disaccharides; Humans; Lysosomes; Microtubule-Associated Proteins; Neurons; Parkinson Disease; Primary Cell Culture; Protein Aggregation, Pathological; Rats; RNA-Binding Proteins; Trehalose

2017
Paradoxical Effect of Trehalose on the Aggregation of α-Synuclein: Expedites Onset of Aggregation yet Reduces Fibril Load.
    ACS chemical neuroscience, 2018, 06-20, Volume: 9, Issue:6

    Topics: alpha-Synuclein; Amyloid; Humans; Molecular Dynamics Simulation; Parkinson Disease; Protein Aggregation, Pathological; Protein Conformation; Trehalose

2018
Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.
    Pharmacology, biochemistry, and behavior, 2019, Volume: 177

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autophagy; Behavior, Animal; Cognition; Corpus Striatum; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Drug Therapy, Combination; Male; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; MPTP Poisoning; Neuroprotective Agents; Neurotoxins; Parkinson Disease; Sirolimus; Substantia Nigra; Trehalose; Tyrosine 3-Monooxygenase

2019
Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose.
    Scientific reports, 2019, 01-24, Volume: 9, Issue:1

    Topics: alpha-Synuclein; Animals; Autophagy; Cell Line, Tumor; Escherichia coli; Glioma; Humans; Lysosomes; Neurons; Parkinson Disease; Protein Aggregation, Pathological; Rats; Rats, Wistar; Recombinant Proteins; Sirolimus; Trehalose

2019
The issue of waste disposal in Parkinson's disease pathogenesis.
    Movement disorders : official journal of the Movement Disorder Society, 2019, Volume: 34, Issue:7

    Topics: alpha-Synuclein; Humans; Lysosomes; Neurons; Parkinson Disease; Trehalose

2019
Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
    Molecular neurobiology, 2016, Volume: 53, Issue:4

    Topics: alpha-Synuclein; Animals; Autophagy; Behavior, Animal; Blood Glucose; Cattle; Cell Survival; Dependovirus; Disease Models, Animal; Dopaminergic Neurons; Extremities; Female; Humans; Microtubule-Associated Proteins; Parkinson Disease; Rats, Sprague-Dawley; Solubility; Substantia Nigra; Trehalose; Tyrosine 3-Monooxygenase

2016
Trehalose does not improve neuronal survival on exposure to alpha-synuclein pre-formed fibrils.
    Redox biology, 2017, Volume: 11

    Topics: alpha-Synuclein; Animals; Apoptosis; Autophagy; Cell Survival; Humans; Mice; Neurons; Parkinson Disease; Protein Aggregation, Pathological; TOR Serine-Threonine Kinases; Trehalose

2017
Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein.
    The Journal of biological chemistry, 2007, Feb-23, Volume: 282, Issue:8

    Topics: alpha-Synuclein; Animals; Antibiotics, Antineoplastic; Autophagy; Chlorocebus aethiops; COS Cells; HeLa Cells; Humans; Huntingtin Protein; Huntington Disease; Mice; Molecular Chaperones; Mutation; Nerve Tissue Proteins; Nuclear Proteins; Parkinson Disease; Protein Kinases; Sirolimus; TOR Serine-Threonine Kinases; Trehalose

2007